eMurmur ID vs EchoSolv AS
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if your primary need is real-time, AI-powered detection and classification of heart murmurs during a physical examination using an electronic stethoscope. This tool is ideal for general practitioners, family medicine, and pediatricians who require immediate decision support for initial screening and identifying various types of murmurs.
View eMurmur ID →Choose EchoSolv AS if…
Choose EchoSolv AS if your focus is on accurately identifying patients at high risk for severe aortic stenosis by analyzing existing echocardiogram measurements. This platform is best suited for cardiology and cardiothoracic surgery departments seeking to streamline the review of echocardiograms, prioritize studies, and provide a second reader opinion for severe AS probability.
View EchoSolv AS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | EchoSolv AS |
|---|---|---|
| Deployment | Cloud, Mobile, API integration | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASWhile Tool A offers a flexible mobile and web interface with third-party stethoscope compatibility, Tool B's focus on seamless integration into existing PACS workflows without requiring EMR integration, coupled with ultra-fast analysis (under 3 seconds), likely provides a more frictionless and efficient user experience for cardiologists. Its measurement-based AI also simplifies data input.
Clinical Value
EchoSolv ASWhile eMurmur ID offers valuable screening for general heart murmurs, EchoSolv AS focuses on a specific, severe, and often underdiagnosed condition (aortic stenosis) where early and accurate detection has a profound impact on patient outcomes. Its demonstrated near-perfect accuracy and ability to outperform human interpretation in detecting severe AS, including in complex low-flow states, provides a more critical and impactful clinical value.
Pricing & Value
TieBoth tools require contacting the vendor for specific pricing, lacking transparency. While EchoSolv AS has an identified reimbursement pathway with a fee-per-use model, the actual cost to the customer and the overall value proposition without a clear price structure for either remains opaque.
Enterprise Readiness
eMurmur IDBoth are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating strong regulatory adherence. However, Tool A offers more flexible deployment options including on-premise and hybrid, which can be crucial for larger enterprises with specific IT infrastructure, data residency, or security requirements. Additionally, Tool A explicitly lists integration with major EHRs like Epic and Cerner, alongside PACS.
Innovation
EchoSolv ASWhile eMurmur ID's point-of-care AI auscultation is innovative, EchoSolv AS demonstrates a more specialized and arguably more advanced innovation by leveraging measurement-based AI to analyze existing echocardiogram data for severe aortic stenosis. Its ability to identify high-risk patients, including those missed by traditional methods, and its training on a vast echo-linked mortality database, highlights a sophisticated approach to a critical diagnostic challenge.
Support & Docs
TieNeither tool provides comprehensive public details regarding their support channels, documentation, or customer success programs in the provided information or readily available web searches. Both mention 'contact us' or 'feedback & support' but lack specifics on the breadth and depth of their support offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | EchoSolv AS |
|---|---|---|
| Name | eMurmur ID | EchoSolv AS |
| Company | CSD Labs GmbH | Echo IQ |
| Description | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. |
| Primary Function | Detecting and classifying heart murmurs | Identifying patients at risk for severe aortic stenosis from echocardiograms |
| Key Features | AI-based analytics for heart murmur detection and classification, Mobile app for recording and displaying heart sounds, Web portal for data management and review, Operates with 3rd party electronic stethoscopes (e.g., Littmann 3200, Thinklabs One), Identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds, Real-time feedback/analysis results within seconds, Patient data management, Clinical decision support | AI-powered clinical decision support for severe aortic stenosis probability, Consistent severe AS probability and guideline check from measurements, Second reader support to help prioritize studies for closer review, Real-world readiness; AI does not use LVOT measurements, Faster clinical review using standardized, measurement-based AI and guideline analysis, Measurement-based AI (analyzes numerical measurements, not images), Designed to fit existing workflows (no EMR integration required, integrates with PACS), Ultra-fast risk detection (under 3 seconds) |
| Specialties | Cardiology, Family Medicine, Pediatrics | Cardiology, Cardiothoracic Surgery |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and EchoSolv AS.